Ackman Short Herbalife May Jump 26% More in Analyst Views
This article is for subscribers only.
Not to digress, but it’s sort of funny that an analyst would give an “overweight” rating to a company that sells diet shakes.
Anyway, that’s the view from Barclays Plc’s Meredith Adler, whose $94 price target on Herbalife Ltd. is the highest on Wall Street and implies another 39 percent rally in the shares from yesterday’s close. The average 12-month price estimate is $85.50, which would be a 26 percent gain, according to data compiled by Bloomberg. (That’s based on four estimates made in the last three months. By comparison, Apple Inc. has 46.)